Wolfson Centre for Young People's Mental Health, Cardiff University, Cardiff, UK.
Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, UK.
J Child Psychol Psychiatry. 2024 Jan;65(1):42-51. doi: 10.1111/jcpp.13862. Epub 2023 Jul 19.
Depression and anxiety are the most common mental health problems in young people. Currently, clinicians are advised to wait before initiating treatment for young people with these disorders as many spontaneously remit. However, others develop recurrent disorder but this subgroup cannot be identified at the outset. We examined whether psychiatric polygenic scores (PGS) could help inform stratification efforts to predict those at higher risk of recurrence.
Probable emotional disorder was examined in two UK population cohorts using the emotional symptoms subscale of the Strengths and Difficulties Questionnaire (SDQ). Those with emotional disorder at two or more time points between ages 5 and 25 years were classed as 'recurrent emotional disorder' (n = 1,643) and those with emotional disorder at one time point as having 'single episode emotional disorder' (n = 1,435, controls n = 8,715). We first examined the relationship between psychiatric PGS and emotional disorders in childhood and adolescence. Second, we tested whether psychiatric PGS added to predictor variables of known association with emotional disorder (neurodevelopmental comorbidity, special educational needs, family history of depression and socioeconomic status) when discriminating between single-episode and recurrent emotional disorder. Analyses were conducted separately in individuals of European and South Asian ancestry.
Probable emotional disorder was associated with higher PGS for major depressive disorder (MDD), anxiety, broad depression, ADHD and autism spectrum disorder (ASD) in those of European ancestry. Higher MDD and broad depression PGS were associated with emotional disorder in people of South Asian ancestry. Recurrent, compared to single-episode, emotional disorder was associated with ASD and parental psychiatric history. PGS were not associated with episode recurrence, and PGS did not improve discrimination of recurrence when combined with clinical predictors.
Our findings do not support the use of PGS as a tool to assess the likelihood of recurrence in young people experiencing their first episode of emotional disorder.
抑郁和焦虑是年轻人最常见的心理健康问题。目前,临床医生建议在为患有这些疾病的年轻人开始治疗之前等待,因为许多疾病会自发缓解。然而,其他人会发展为复发性疾病,但这一组在开始时无法识别。我们研究了精神疾病多基因评分(PGS)是否可以帮助确定分层努力,以预测那些复发风险较高的人。
使用 SDQ 的情绪症状子量表在两个英国人群队列中检查可能的情绪障碍。在 5 岁至 25 岁之间有两次或两次以上时间点存在情绪障碍的人被归类为“复发性情绪障碍”(n=1643),而在一次时间点存在情绪障碍的人被归类为“单次发作情绪障碍”(n=1435,对照组 n=8715)。我们首先检查了精神疾病 PGS 与儿童和青少年时期情绪障碍之间的关系。其次,我们测试了精神疾病 PGS 是否在区分单发性和复发性情绪障碍时,增加了与情绪障碍已知关联的预测变量(神经发育合并症、特殊教育需求、抑郁家族史和社会经济地位)。分析分别在欧洲和南亚血统个体中进行。
在欧洲血统个体中,与 MDD、焦虑、广泛抑郁、ADHD 和自闭症谱系障碍(ASD)相关的 PGS 与较高的可能情绪障碍相关。南亚血统个体中,较高的 MDD 和广泛抑郁 PGS 与情绪障碍相关。与单发性发作相比,复发性情绪障碍与 ASD 和父母的精神病史相关。PGS 与发作复发无关,PGS 与临床预测因子结合使用并未提高复发的区分能力。
我们的研究结果不支持将 PGS 作为评估首次经历情绪障碍的年轻人复发可能性的工具。